.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Merck
Citi
Chubb
Daiichi Sankyo
Queensland Health
Cerilliant
AstraZeneca
US Department of Justice
Cantor Fitzgerald

Generated: November 17, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: nintedanib esylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Boehringer Ingelheim
OFEV
nintedanib esylate
CAPSULE;ORAL205832NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0143-601 BOTTLE in 1 CARTON (0597-0143-60) > 60 CAPSULE in 1 BOTTLE
Boehringer Ingelheim
OFEV
nintedanib esylate
CAPSULE;ORAL205832NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0145-601 BOTTLE in 1 CARTON (0597-0145-60) > 60 CAPSULE in 1 BOTTLE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Cipla
US Army
Moodys
Cantor Fitzgerald
Farmers Insurance
UBS
Novartis
Chinese Patent Office
McKinsey

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot